{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:42Z","timestamp":1767135402266,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":50,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003584","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T17:14:00Z","timestamp":1069434840000},"source":"Crossref","is-referenced-by-count":30,"title":["Oral treatments for fungal infections of the skin of the foot."],"prefix":"10.1002","author":[{"given":"Sally EM","family":"Bell-Syer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,22]]},"reference":[{"issue":"suppl 43","key":"10.1002\/14651858.CD003584-BIB1|cit1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2133.1994.tb06089.x","article-title":"Two week oral treatment of tinea pedis, comparing terbinafine (250mg\/day) with itraconazole (100mg\/day): a double blind multicentre study","volume":"130","author":"Keyser","year":"1994","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB2|cit2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0926-9959(95)00027-B","article-title":"A double blind study comparison of itraconazole and fluconazole in tinea pedis and tinea manuum","volume":"4","author":"Difonzo","year":"1995","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"suppl 2","key":"10.1002\/14651858.CD003584-BIB3|cit3","first-page":"12","article-title":"Comparative evaluation of oral fluconazole and oral ketoconazole in the treatment of fungal infections of the skin","volume":"31","author":"Fischbein","year":"1992","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB4|cit4","first-page":"604","article-title":"A comparison of 2 weeks terbinafine 250mg\/day with 4 weeks of itraconazole 100mg\/day in plantar - type tinea pedis","volume":"132 132","author":"Hay","year":"1995","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB5|cit5","series-title":"Terbinafine in the treatment of superficial fungal infections. Asia-Pacific symposium on lamisil. Papers","first-page":"17","article-title":"Single blind randomised study of terbinafine vs itraconazole in tinea pedis (two weeks vs four weeks)","author":"Kim","year":"1993"},{"key":"10.1002\/14651858.CD003584-BIB6|cit6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-4362.1998.00541.x","article-title":"A comparison of the efficacy of oral fluconazole, 150 mg\/week versus 50 mg\/day, in the treatment of tinea corporis, tinea cruris, tinea pedis and cutaneous candidosis","volume":"37","author":"Nozickova","year":"1998","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB7|cit7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/02681218780000421","article-title":"Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis.","volume":"25","author":"Roberts","year":"1987","journal-title":"Journal of Medical and Veterinary Mycology"},{"key":"10.1002\/14651858.CD003584-BIB8|cit8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0190-9622(90)70293-Q","article-title":"Treatment of chronic moccasin type tinea pedis with terbinafine","volume":"23","author":"Savin","year":"1990","journal-title":"Journal of American Academy of Dermatology"},{"issue":"suppl 2","key":"10.1002\/14651858.CD003584-BIB9|cit9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/09546639009089032","article-title":"Terbinafine (Lamisil) versus griseofulvin in moccasin type tinea pedis","volume":"1","author":"Savin","year":"1990","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1002\/14651858.CD003584-BIB10|cit10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000018033","article-title":"Efficacy and safety of short-term itraconazole in tinea pedis: a double-blind, randomized, placebo-controlled trial","volume":"197","author":"Svejgaard","year":"1998","journal-title":"Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB11|cit11","series-title":"Terbinafine in the treatment of superficial fungal infections. Asia-Pacific symposium on lamisil. Papers","first-page":"11","article-title":"Double blind comparative study of the efficacy and tolerability of terbinafine with itraconazole in patients with tinea pedis","author":"Voravutinon","year":"1993"},{"key":"10.1002\/14651858.CD003584-BIB12|cit12","series-title":"Terbinafine in the treatment of superficial fungal infections. Asia-Pacific symposium on lamisil. Papers","first-page":"21","article-title":"A randomised double blind comparative study of terbinafine vs griseofulvin in tinea pedis","author":"Widyanto","year":"1993"},{"key":"10.1002\/14651858.CD003584-BIB13|cit13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2133.1998.02466.x","article-title":"Comparison of one week of oral terbinafine (250mg\/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis","volume":"139","author":"Barnetson","year":"1998","journal-title":"British Journal of Dermatology"},{"issue":"suppl 1","key":"10.1002\/14651858.CD003584-BIB14|cit14","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1093\/clinids\/9.Supplement_1.S104","article-title":"Itraconazole in the treatment of dermatophytoses: a comparison of two daily dosages","volume":"9","author":"Degreef","year":"1987","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD003584-BIB15|cit15","first-page":"45","article-title":"Double blind randomised comparative study on tinea manuum and tinea pedis treated with itraconazole and griseofulvin","volume":"84","author":"Palacio","year":"1993","journal-title":"Actas Dermo-Sifiligro"},{"key":"10.1002\/14651858.CD003584-BIB16|cit16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0190-9622(91)70035-Z","article-title":"A comparative study of terbinafine versus griseofulvin in 'dry - type' dermatophyte infections","volume":"24","author":"Hay","year":"1991","journal-title":"Journal of American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB17|cit17","first-page":"208","article-title":"A multicentre double blind evaluation of ketoconazole in the treatment of dermatomycoses","volume":"31","author":"Jolly","year":"1983","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD003584-BIB18|cit18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinids\/2.4.586","article-title":"A multicentre double blind comparison of ketoconazole and griseofulvin in the treatment of infections due to dermatophytes","volume":"2","author":"Legendre","year":"1980","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD003584-BIB19|cit19","first-page":"460","article-title":"Treatment of tinea pedis with micronized griseofulvin and tolnaftate","volume":"13","author":"Lynfield","year":"1974","journal-title":"Cutis"},{"key":"10.1002\/14651858.CD003584-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(60)91038-2","article-title":"Chronic ringworm infection of the skin and nails treated with griseofulvin: report of a therapeutic trial","volume":"1","author":"Russell","year":"1960","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003584-BIB21|cit21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2230.1989.tb00906.x","article-title":"Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil)","volume":"14","author":"Savin","year":"1989","journal-title":"Clinical Experimental Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003584-BIB22|cit22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0190-9622(90)70294-R","article-title":"Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis","volume":"23","author":"Savin","year":"1990","journal-title":"Journal of American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB23|cit23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1439-0507.1998.tb00715.x","article-title":"Itraconazole in the treatment of tinea pedis and tinea manuum: comparison of two treatment schedules","volume":"41","author":"Schuller","year":"1998","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD003584-BIB24|cit24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-4362.1998.00402.x","article-title":"Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus","volume":"37","author":"Tausch","year":"1998","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB25|cit25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1439-0507.1988.tb04419.x","article-title":"Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum","volume":"31","author":"Hecke","year":"1988","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD003584-BIB26|cit26","first-page":"126","article-title":"A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus","volume":"107","author":"Wishart","year":"1994","journal-title":"New Zealand Medical Journal"},{"key":"10.1002\/14651858.CD003584-BIB27|cit27","first-page":"7","article-title":"Clinical comparative study of terbinafine and itraconazole in the treatment of tinea pedis.","volume":"205","author":"Won","year":"1993","journal-title":"Shuster S & Jafary MH (Ed) Royal Society of Medicine Services Ltd Int. Congress & Symposium series"},{"key":"10.1002\/14651858.CD003584-BIB28|cit28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1439-0507.1993.tb00685.x","article-title":"Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete\u2019s foot","volume":"36","author":"Auger","year":"1993","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD003584-BIB29|cit29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jnci\/81.2.107","article-title":"Publication bias and dissemination of clinical research.","volume":"81","author":"Begg","year":"1989","journal-title":"Journal of the National Cancer Institute"},{"issue":"8","key":"10.1002\/14651858.CD003584-BIB30|cit30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of randomised controlled trials. The CONSORT Statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"7, Oct","key":"10.1002\/14651858.CD003584-BIB31|cit31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bmj.311.7010.919","article-title":"Randomised double blind comparison of terbinafine and itraconazole for the treatment of toenail tinea infection","volume":"vol 311","author":"Brautigam","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003584-BIB32|cit32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0891-8422(23)00779-6","article-title":"Tinea pedis diagnosis and treatment","volume":"13","author":"Brooks","year":"1996","journal-title":"Clinics in Podiatric Medicine and Surgery"},{"key":"10.1002\/14651858.CD003584-BIB33|cit33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/jrnms-61-92","article-title":"The incidence and epidemiology of tinea pedis in the crew of a nuclear submarine","volume":"61","author":"Catterall","year":"1975","journal-title":"Journal Nav. Med. Serv"},{"issue":"1","key":"10.1002\/14651858.CD003584-BIB34|cit34","article-title":"Topical treatments for fungal infections of the skin and nails of the foot","author":"Crawford","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003584-BIB35|cit35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1439-0507.1995.tb00029.x","article-title":"Fungal contamination of the floors of swimming pools, particularly subtropical swimming paradises","volume":"38","author":"Detandt","year":"1995","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD003584-BIB36|cit36","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0190-9622(96)90062-6","article-title":"Diagnostic techniques for confirming onychomycosis","volume":"35","author":"Elewski","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.1.5135.1442","article-title":"Studies in the epidemiology of tinea pedis I. Tinea pedis in school children","volume":"1","author":"English","year":"1959","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003584-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/bmj.1.5232.1083","article-title":"Studies in the epidemiology of tinea pedis: VI Tinea pedis in a boarding school","volume":"1","author":"English","year":"1961","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003584-BIB39|cit39","volume-title":"Statistics with Confidence","author":"Gardner","year":"1989"},{"key":"10.1002\/14651858.CD003584-BIB40|cit40","first-page":"22","article-title":"Foot ringworm in coal miners","volume":"14","author":"Gentles","year":"1957","journal-title":"British Journal of Industrial Medicine"},{"key":"10.1002\/14651858.CD003584-BIB41|cit41","doi-asserted-by":"crossref","first-page":"260 - 262","DOI":"10.1136\/bmj.3.5874.260","article-title":"Foot infections in swimming baths","volume":"3","author":"Gentles","year":"1973","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD003584-BIB42|cit42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0190-9622(08)81495-8","article-title":"Antifungal agents: An overview. Part 1","volume":"30","author":"Gupta","year":"1994","journal-title":"Journal of American Academy of Dermatology,"},{"issue":"5","key":"10.1002\/14651858.CD003584-BIB43|cit43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(94)70112-1","article-title":"Antifungal agents: An overview. Part 2","volume":"30","author":"Gupta","year":"1994","journal-title":"Journal of American Academy of Dermatology,"},{"key":"10.1002\/14651858.CD003584-BIB44|cit44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.319.7202.79","article-title":"Systematic review of topical treatment for fungal infections of the skin and nails of the feet","volume":"319","author":"Hart","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003584-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the Quality of Reports of Randomised Clinical Trials: Is Blinding Necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003584-BIB46|cit46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archderm.1982.01650160007009","article-title":"Ketoconazole","volume":"118","author":"Jones","year":"1982","journal-title":"Archives Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB47|cit47","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-2133.1999.02822.x","article-title":"The prevalence of common skin conditions in Australian school students: 4 Tinea Pedis","volume":"140","author":"Merlin","year":"1999","journal-title":"British J Dermatology"},{"key":"10.1002\/14651858.CD003584-BIB48|cit48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0197-2456(94)00031-W","article-title":"Assessing the quality of Randomised Controlled Trials: An Annotated Bibliography of Scales and Checklists","volume":"16","author":"Moher","year":"1995","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD003584-BIB49|cit49","volume-title":"Undertaking systematic reviews of research on effectiveness","year":"1996"},{"issue":"suppl 1","key":"10.1002\/14651858.CD003584-BIB50|cit50","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0926-9959(99)00053-7","article-title":"Achilles foot screening project: preliminary results of patients screened by dermatologists","volume":"12","author":"Roseeuw","year":"1999","journal-title":"Journal of the European Academy of Dermatology and Venereology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003584.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T00:00:00Z","timestamp":1350432000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003584\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:49:27Z","timestamp":1704962967000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003584"}},"subtitle":[],"editor":[{"given":"Sally EM","family":"Bell-Syer","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2002,4,22]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003584","relation":{},"subject":[],"published":{"date-parts":[[2002,4,22]]}}}